Public trial registry of the CCC-Munich

Trial AIO KRK-0116 / FIRE-4.5

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AIO KRK-0116 / FIRE-4.5
World
Full title
:

Randomisierte Studie zur Untersuchung von FOLFOXIRI plus Cetuximab vs. FOLFOXIRI plus Bevacizumab als Erstbehandlung von BRAF-mutiertem metastasiertem Kolorektalkarzinom

World
EudraCT number
:
2015-004849-11
World
NCT number
:
NCT04034459
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
ICD-10-GM C18.- Bösartige Neubildung des Kolons
- Colorectal carcinoma
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2023-12-31 / Unknown
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization
World Principal Investigator VOLKER HEINEMANN Keine Organisationseinheit angegeben Magnifier
Printer
 
Application_get